Alamo, CA, United States of America

David Y Chien

This inventor holds 32 USPTO granted patents, plus 4 CIPO patents and 6 EPO patents. Top assignees: Chiron Corporation, Novartis Vaccines & Diagnostics, Gmbh, Ortho-Clinical Diagnostics, Inc. Active years: 2000-2020.


% Patents Active = 90.6


 

Average Co-Inventor Count = 3.0

ph-index = 8

Forward Citations = 198(Granted Patents)


Location History:

  • Emeryville, CA (US) (2002 - 2009)
  • Alamo, CA (US) (2000 - 2020)

Company Filing History:


Years Active: 2000-2020

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
HCV NS4A Polypeptides
Hepatitis B Surface Antigens
Immunogenic Reagents
Monoclonal Antibodies
Multiple Epitope Fusion Antigens
Biochips
Immunoassays
Protease Regulator Screening
NANBV Diagnostics
HCV Antigen Detection
Intracellular Production
Antibody Detection Methods
32 patents (USPTO):Explore Patents

Title: The Inventor David Y Chien: Pioneering Innovations in Alamo, CA

Introduction: David Y Chien is a distinguished inventor based in Alamo, CA, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: David Y Chien holds several patents in the areas of technology and healthcare, showcasing his versatility and expertise in developing cutting-edge solutions.

Career Highlights: With a career spanning over two decades, David Y Chien has consistently pushed the boundaries of technology, earning recognition for his impactful inventions that have revolutionized industries.

Collaborations: Throughout his career, David Y Chien has collaborated with leading research institutions, universities, and companies to bring his ideas to life, fostering a culture of innovation and excellence.

Conclusion: David Y Chien's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors, leaving a lasting impact on the world of technology and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…